SKI Market

Indian Indices

Nifty

22,403.85 203.30
(0.92%)

Sensex

73,852.11 188.39
( 0.26%)

Bank Nifty

47,977.05 289.60
( 0.61%)

Nifty IT

33,668.45 551.05
( 1.66%)

Global Indices

Nasdaq

16,698.32 -44.07
(-0.26%)

Dow Jones

39,869.38 -38.62
(-0.10%)

Hang Seng

19,376.53 302.82
(1.59%)

Nikkei 225

38,920.26 534.53
(1.39%)

Forex

USD-INR

83.46 -0.04
(-0.05%)

EUR-INR

90.54 0.34
(0.38%)

GBP-INR

105.44 0.50
(0.48%)

JPY-INR

0.54 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

540204

INE666Q01016

40.4431748

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

84.26

63.84

EPS(TTM)

Face Value()

Div & Yield %

0.61

Back

narendra investments delhi ltd

Eiko Lifesciences standalone net profit declines 20.00% in the September 2023 quarter

Nov 09,2023

Net profit of Eiko Lifesciences declined 20.00% to Rs 0.12 crore in the quarter ended September 2023 as against Rs 0.15 crore during the previous quarter ended September 2022. Sales rose 48.72% to Rs 6.41 crore in the quarter ended September 2023 as against Rs 4.31 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	6.41	4.31	49
OPM %	5.46	3.25	-
PBDT	0.32	0.36	-11
PBT	0.16	0.20	-20
NP	0.12	0.15	-20

22,403.85 203.30 (0.92%)

73,852.11 188.39 ( 0.26%)

47,977.05 289.60 ( 0.61%)

33,668.45 551.05 ( 1.66%)

16,698.32 -44.07 (-0.26%)

39,869.38 -38.62 (-0.10%)

19,376.53 302.82 (1.59%)

38,920.26 534.53 (1.39%)

83.46 -0.04 (-0.05%)

90.54 0.34 (0.38%)

105.44 0.50 (0.48%)

0.54 0.00 (0.51%)